Search

Your search keyword '"Hemangioblastoma metabolism"' showing total 111 results

Search Constraints

Start Over You searched for: Descriptor "Hemangioblastoma metabolism" Remove constraint Descriptor: "Hemangioblastoma metabolism"
111 results on '"Hemangioblastoma metabolism"'

Search Results

1. Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas.

2. α-SMA positive vascular mural cells suppress cyst formation in hemangioblastoma.

3. Sporadic Cerebellar Hemangioblastoma With Strong SSTR Expression on 68 Ga-DOTANOC PET/CT.

4. Developmentally Arrested Basket/Stellate Cells in Postnatal Human Brain as Potential Tumor Cells of Origin for Cerebellar Hemangioblastoma in von Hippel-Lindau Patients.

5. Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma.

6. Hemangioblastoma: An Unsuspected Pitfall in PSMA PET/CT.

7. Combined transcriptomic and lipidomic analysis reveals aberrant lipid metabolism in central nervous system hemangioblastomas.

8. Role of VHL-JAK-STAT signaling pathway in central nervous system hemangioblastoma associated with von Hippel-Lindau disease.

9. Metastatic Renal Cell Carcinoma to the Brain: A Contemporary Clinicopathologic Analysis With Comparison of Immunohistochemical Profiles to Selected Primary Brain Tumors With Clear Cell Features.

10. Rb1/Rbl1/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma.

11. The β2-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease.

12. Magnetic resonance spectroscopy in posterior fossa tumours: the tumour spectroscopic signature may improve discrimination in adults among haemangioblastoma, ependymal tumours, medulloblastoma, and metastasis.

13. 68Ga DOTATATE PET/CT Versus 18F-FDG PET/CT for Detecting Intramedullary Hemangioblastoma in a Patient With Von Hippel-Lindau Disease.

14. Stromal cells of hemangioblastomas exhibit mesenchymal stem cell-derived vascular progenitor cell properties.

15. Exploring the role of defective fibronectin matrix assembly in the VHL-associated CNS hemangioblastoma.

16. Von Hippel-Lindau with early onset of hemangioblastoma and multiple drop-metastases like spinal lesions: A case report.

17. Characteristics of time-activity curves obtained from dynamic 11 C-methionine PET in common primary brain tumors.

18. A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay.

19. Deletion of the von Hippel-Lindau Gene in Hemangioblasts Causes Hemangioblastoma-like Lesions in Murine Retina.

20. MicroRNA-137 and microRNA-195* inhibit vasculogenesis in brain arteriovenous malformations.

21. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization.

22. 18F-FDG and 68Ga-DOTATATE PET/CT in von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma.

23. Expression of angiopoietins in central nervous system hemangioblastomas is associated with cyst formation.

24. Study of angiogenic signaling pathways in hemangioblastoma.

25. Loss of Quiescence in von Hippel-Lindau Hemangioblastomas is Associated with Erythropoietin Signaling.

26. CD41 and CD45 expression marks the angioformative initiation of neovascularisation in human haemangioblastoma.

27. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas.

28. Recurrence rates and functional outcome after resection of intrinsic intramedullary tumors.

29. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.

30. VHL-deficient vasculogenesis in hemangioblastoma.

31. In vivo and ex vivo magnetic resonance spectroscopy in the characterization of hemangioblastoma cyst fluid.

32. Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers.

33. Expression of HIF-1 regulated proteins vascular endothelial growth factor, carbonic anhydrase IX and hypoxia inducible gene 2 in hemangioblastomas.

34. [Clinicopathologic characteristics of sporadic renal hemangioblastoma].

35. PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis.

36. Von hippel-lindau disease: a genetic and clinical review.

37. [New entities of soft tissue tumors].

38. Hypoxia mediated expression of stem cell markers in VHL-associated hemangioblastomas.

39. Galectin-3: a novel protein in cerebellar hemangioblastoma.

40. Hemangioblastoma of the gastrointestinal tract: a first case.

41. Hemangioblastoma-like clear cell stromal tumor of the lung.

43. Sporadic hemangioblastoma of the kidney in a 29-year-old man.

44. Sporadic haemangioblastoma of the kidney with rhabdoid features and focal CD10 expression: report of a case and literature review.

45. Coexistence of sporadic cerebellar hemangioblastoma and pituitary null cell adenoma: simultaneous expression of von Hippel-Lindau gene product. Case report.

46. Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease.

47. Identification of tumorigenic cells and implication of their aberrant differentiation in human hemangioblastomas.

48. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.

49. Developmentally arrested structures preceding cerebellar tumors in von Hippel-Lindau disease.

50. Sporadic hemangioblastoma of the kidney: an underrecognized pseudomalignant tumor?

Catalog

Books, media, physical & digital resources